{"id":933896,"date":"2025-10-22T14:13:13","date_gmt":"2025-10-22T14:13:13","guid":{"rendered":"https:\/\/ukpostcode.org\/content\/?p=933896"},"modified":"2025-10-22T14:13:13","modified_gmt":"2025-10-22T14:13:13","slug":"major-funding-round-for-brain-scan-startup-comind","status":"publish","type":"post","link":"https:\/\/ukpostcode.org\/content\/major-funding-round-for-brain-scan-startup-comind\/","title":{"rendered":"Major Funding Round for Brain Scan Startup CoMind"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_73 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-1'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ukpostcode.org\/content\/major-funding-round-for-brain-scan-startup-comind\/#Major_funding_round_for_brain-scan_startup_CoMind_%E2%80%94_full_detailed_report\" title=\"Major funding round for brain-scan startup CoMind \u2014 full detailed report\">Major funding round for brain-scan startup CoMind \u2014 full detailed report<\/a><ul class='ez-toc-list-level-2' ><li class='ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ukpostcode.org\/content\/major-funding-round-for-brain-scan-startup-comind\/#Quick_summary_TLDR\" title=\"Quick summary (TL;DR)\">Quick summary (TL;DR)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ukpostcode.org\/content\/major-funding-round-for-brain-scan-startup-comind\/#The_round_%E2%80%94_who_how_much_and_why_it_matters\" title=\"The round \u2014 who, how much, and why it matters\">The round \u2014 who, how much, and why it matters<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ukpostcode.org\/content\/major-funding-round-for-brain-scan-startup-comind\/#The_product_and_the_technology_what_CoMind_One_does\" title=\"The product and the technology (what CoMind One does)\">The product and the technology (what CoMind One does)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ukpostcode.org\/content\/major-funding-round-for-brain-scan-startup-comind\/#Founder_team_%E2%80%94_origin_story_and_leadership\" title=\"Founder &amp; team \u2014 origin story and leadership\">Founder &amp; team \u2014 origin story and leadership<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ukpostcode.org\/content\/major-funding-round-for-brain-scan-startup-comind\/#Use_of_proceeds_%E2%80%94_where_the_cash_will_go\" title=\"Use of proceeds \u2014 where the cash will go\">Use of proceeds \u2014 where the cash will go<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ukpostcode.org\/content\/major-funding-round-for-brain-scan-startup-comind\/#Market_opportunity_clinical_impact\" title=\"Market opportunity &amp; clinical impact\">Market opportunity &amp; clinical impact<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/ukpostcode.org\/content\/major-funding-round-for-brain-scan-startup-comind\/#Risks_and_challenges\" title=\"Risks and challenges\">Risks and challenges<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/ukpostcode.org\/content\/major-funding-round-for-brain-scan-startup-comind\/#Whats_next_timeline\" title=\"What\u2019s next \/ timeline\">What\u2019s next \/ timeline<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/ukpostcode.org\/content\/major-funding-round-for-brain-scan-startup-comind\/#Sources_further_reading\" title=\"Sources &amp; further reading\">Sources &amp; further reading<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-1'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/ukpostcode.org\/content\/major-funding-round-for-brain-scan-startup-comind\/#Case_studies\" title=\"Case studies\">Case studies<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/ukpostcode.org\/content\/major-funding-round-for-brain-scan-startup-comind\/#Case_study_A_%E2%80%94_Neuro-critical_care_traumatic_brain_injury_TBI_%E2%80%94_earlier_intervention\" title=\"Case study A \u2014 Neuro-critical care: traumatic brain injury (TBI) \u2014 earlier intervention\">Case study A \u2014 Neuro-critical care: traumatic brain injury (TBI) \u2014 earlier intervention<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/ukpostcode.org\/content\/major-funding-round-for-brain-scan-startup-comind\/#Case_study_B_%E2%80%94_Perioperative_monitoring_in_high-risk_cardiac_surgery\" title=\"Case study B \u2014 Perioperative monitoring in high-risk cardiac surgery\">Case study B \u2014 Perioperative monitoring in high-risk cardiac surgery<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/ukpostcode.org\/content\/major-funding-round-for-brain-scan-startup-comind\/#Case_study_C_%E2%80%94_Stroke_subarachnoid_hemorrhage_monitoring_recovery_secondary_deterioration\" title=\"Case study C \u2014 Stroke \/ subarachnoid hemorrhage (monitoring recovery &amp; secondary deterioration)\">Case study C \u2014 Stroke \/ subarachnoid hemorrhage (monitoring recovery &amp; secondary deterioration)<\/a><\/li><\/ul><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-1'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/ukpostcode.org\/content\/major-funding-round-for-brain-scan-startup-comind\/#Comments_%E2%80%94_what_this_round_means_quick_bullets\" title=\"Comments \u2014 what this round means (quick bullets)\">Comments \u2014 what this round means (quick bullets)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-1'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/ukpostcode.org\/content\/major-funding-round-for-brain-scan-startup-comind\/#Suggested_follow-ups_I_can_do_these_next\" title=\"Suggested follow-ups (I can do these next)\">Suggested follow-ups (I can do these next)<\/a><\/li><\/ul><\/nav><\/div>\n<h1><span class=\"ez-toc-section\" id=\"Major_funding_round_for_brain-scan_startup_CoMind_%E2%80%94_full_detailed_report\"><\/span>Major funding round for brain-scan startup CoMind \u2014 full detailed report<span class=\"ez-toc-section-end\"><\/span><\/h1>\n<p><strong>Headline:<\/strong> CoMind pulls in $60M Series A (part of $102.5M total) to commercialize a non-invasive brain-monitoring device as it recruits for U.S. trials and targets FDA approval. (<a title=\"UK brain monitoring start-up goes from teenage idea to $100mn funding\" href=\"https:\/\/www.ft.com\/content\/1f41a613-c97a-4725-8715-5dd3090f5287?utm_source=chatgpt.com\">Financial Times<\/a>)<\/p>\n<hr \/>\n<h2><span class=\"ez-toc-section\" id=\"Quick_summary_TLDR\"><\/span>Quick summary (TL;DR)<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>London-based neurotech <strong>CoMind<\/strong> announced a financing package that brings its <strong>total funding to $102.5 million<\/strong>, including a <strong>$60 million round led by Plural<\/strong>. The cash will accelerate clinical trials, regulatory clearance efforts (U.S. FDA), scale manufacturing and expand the team. (<a title=\"CoMind announces $102.5m funding to redefine clinical ...\" href=\"https:\/\/www.comind.io\/news\/comind-announces-102-5m-funding-to-redefine-clinical-monitoring-of-the-brain?utm_source=chatgpt.com\">comind.io<\/a>)<\/li>\n<li>CoMind is developing <strong>CoMind One<\/strong>, a non-invasive photonics device that measures cerebral blood flow, intracranial pressure (ICP) and autoregulation through the skull using low-power infrared lasers and advanced optics + compute. The company positions this as an alternative to invasive intracranial bolts and a continuous bedside monitor for ICUs and operating theatres. (<a title=\"UK brain monitoring start-up goes from teenage idea to $100mn funding\" href=\"https:\/\/www.ft.com\/content\/1f41a613-c97a-4725-8715-5dd3090f5287?utm_source=chatgpt.com\">Financial Times<\/a>)<\/li>\n<li>The company has run clinical studies in London and Barcelona and is <strong>recruiting for a third clinical trial in the U.S.<\/strong> with an eye toward FDA approval and a possible commercial launch in the coming years. Manufacturing partnerships and production planning are already underway. (<a title=\"UK brain monitoring start-up goes from teenage idea to $100mn funding\" href=\"https:\/\/www.ft.com\/content\/1f41a613-c97a-4725-8715-5dd3090f5287?utm_source=chatgpt.com\">Financial Times<\/a>)<\/li>\n<\/ul>\n<hr \/>\n<h2><span class=\"ez-toc-section\" id=\"The_round_%E2%80%94_who_how_much_and_why_it_matters\"><\/span>The round \u2014 who, how much, and why it matters<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>CoMind\u2019s latest financing was led by <strong>Plural<\/strong> (the VC founded by Wise co-founder Taavet Hinrikus), with participation from existing backers including <strong>Angelini Ventures, LocalGlobe, Octopus Ventures, Crane, Backed VC and Entrepreneurs First<\/strong>. The round is commonly reported as <strong>$60M<\/strong> for the Series A portion; CoMind confirms the announcement brings its <strong>total raised to $102.5M<\/strong> to date. The funding signals strong investor conviction in non-invasive neuromonitoring \u2014 a high-impact, regulated healthtech space with both clinical and system-level cost implications. (<a title=\"Plural backs brain monitoring startup CoMind in $60m round\" href=\"https:\/\/sifted.eu\/articles\/plural-brain-monitoring-comind-60m\/?utm_source=chatgpt.com\">Sifted<\/a>)<\/p>\n<p>Why it matters: intracranial pressure and cerebral blood flow are critical data for patients with traumatic brain injury (TBI), stroke, during cardiac surgery, and in intensive care. Current \u201cgold standard\u201d continuous monitoring typically requires drilling into the skull (an invasive bolt), which carries risks and logistical limitations. A reliable non-invasive device could change standard monitoring practices, enable earlier interventions, and reduce complication rates and costs. (<a title=\"UK brain monitoring start-up goes from teenage idea to $100mn funding\" href=\"https:\/\/www.ft.com\/content\/1f41a613-c97a-4725-8715-5dd3090f5287?utm_source=chatgpt.com\">Financial Times<\/a>)<\/p>\n<hr \/>\n<h2><span class=\"ez-toc-section\" id=\"The_product_and_the_technology_what_CoMind_One_does\"><\/span>The product and the technology (what CoMind One does)<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>CoMind One is described as a <strong>photonic, non-invasive brain monitor<\/strong> that uses <strong>low-power infrared lasers<\/strong> and advanced optical sensing to infer cerebral blood flow, intracranial pressure and cerebrovascular autoregulation in real time. The system relies on sophisticated signal processing and GPU-level compute to extract physiological signals through the skull \u2014 the company likens parts of the sensing\/processing approach to lidar and advanced optics used in other industries. The device aims to provide continuous bedside monitoring comparable in clinical value to invasive techniques without surgical insertion. (<a title=\"UK brain monitoring start-up goes from teenage idea to $100mn funding\" href=\"https:\/\/www.ft.com\/content\/1f41a613-c97a-4725-8715-5dd3090f5287?utm_source=chatgpt.com\">Financial Times<\/a>)<\/p>\n<p>Clinical evidence so far: CoMind has completed trials in London and Barcelona demonstrating feasibility; the next step is larger, multi-center studies \u2014 including the U.S. trial currently recruiting \u2014 to support regulatory filings. The company says these studies will underpin claims for safety and performance needed by regulators like the FDA. (<a title=\"UK brain monitoring start-up goes from teenage idea to $100mn funding\" href=\"https:\/\/www.ft.com\/content\/1f41a613-c97a-4725-8715-5dd3090f5287?utm_source=chatgpt.com\">Financial Times<\/a>)<\/p>\n<hr \/>\n<h2><span class=\"ez-toc-section\" id=\"Founder_team_%E2%80%94_origin_story_and_leadership\"><\/span>Founder &amp; team \u2014 origin story and leadership<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>CoMind was founded by <strong>James Dacombe<\/strong>, who started the project as a teenager and left school early to build the company. Dacombe has been a visible founder voice for the firm; in announcing the round he reiterated the company goal of making brain monitoring \u201cas common as having your blood pressure taken.\u201d That narrative \u2014 a mix of founder ambition and a clear clinical problem \u2014 has helped the startup attract investors and clinical collaborators. (<a title=\"UK brain monitoring start-up goes from teenage idea to $100mn funding\" href=\"https:\/\/www.ft.com\/content\/1f41a613-c97a-4725-8715-5dd3090f5287?utm_source=chatgpt.com\">Financial Times<\/a>)<\/p>\n<hr \/>\n<h2><span class=\"ez-toc-section\" id=\"Use_of_proceeds_%E2%80%94_where_the_cash_will_go\"><\/span>Use of proceeds \u2014 where the cash will go<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>According to the company and reporting across outlets, the financing will be used to:<\/p>\n<ul>\n<li><strong>Complete additional clinical trials<\/strong> (including the U.S. study), generate pivotal data for regulatory submissions and expand clinical partnerships. (<a title=\"CoMind announces $102.5m funding to redefine clinical ...\" href=\"https:\/\/www.comind.io\/news\/comind-announces-102-5m-funding-to-redefine-clinical-monitoring-of-the-brain?utm_source=chatgpt.com\">comind.io<\/a>)<\/li>\n<li><strong>Advance regulatory filings<\/strong> with the U.S. Food and Drug Administration (FDA) and other global regulators, a prerequisite for broad clinical adoption and commercial sales in regulated markets. (<a title=\"UK brain monitoring start-up goes from teenage idea to $100mn funding\" href=\"https:\/\/www.ft.com\/content\/1f41a613-c97a-4725-8715-5dd3090f5287?utm_source=chatgpt.com\">Financial Times<\/a>)<\/li>\n<li><strong>Scale manufacturing<\/strong> through partnerships with established electronics\/EMS providers (the company is engaging production partners to prepare for regulated device manufacturing). Reporting notes Benchmark Electronics as a production partner supporting scale-up. (<a title=\"UK brain monitoring start-up goes from teenage idea to $100mn funding\" href=\"https:\/\/www.ft.com\/content\/1f41a613-c97a-4725-8715-5dd3090f5287?utm_source=chatgpt.com\">Financial Times<\/a>)<\/li>\n<li><strong>Grow the team<\/strong> across engineering, clinical affairs, regulatory and commercial functions. (<a title=\"CoMind announces $102.5m funding to redefine clinical ...\" href=\"https:\/\/www.comind.io\/news\/comind-announces-102-5m-funding-to-redefine-clinical-monitoring-of-the-brain?utm_source=chatgpt.com\">comind.io<\/a>)<\/li>\n<\/ul>\n<hr \/>\n<h2><span class=\"ez-toc-section\" id=\"Market_opportunity_clinical_impact\"><\/span>Market opportunity &amp; clinical impact<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The immediate clinical use cases are:<\/p>\n<ul>\n<li>Continuous monitoring in <strong>neuro-critical care<\/strong> (TBI, subarachnoid hemorrhage, severe stroke), where ICP and autoregulation help guide interventions. (<a title=\"UK brain monitoring start-up goes from teenage idea to $100mn funding\" href=\"https:\/\/www.ft.com\/content\/1f41a613-c97a-4725-8715-5dd3090f5287?utm_source=chatgpt.com\">Financial Times<\/a>)<\/li>\n<li>Perioperative monitoring, especially during <strong>cardiac surgery<\/strong> and other high-risk operations where brain perfusion can change rapidly. (<a title=\"UK brain monitoring start-up goes from teenage idea to $100mn funding\" href=\"https:\/\/www.ft.com\/content\/1f41a613-c97a-4725-8715-5dd3090f5287?utm_source=chatgpt.com\">Financial Times<\/a>)<\/li>\n<\/ul>\n<p>If validated and widely adopted, an accurate, continuous, non-invasive monitor could reduce the need for invasive monitoring, speed diagnosis of deteriorating brain states, and potentially shorten ICU stays \u2014 delivering clinical benefits and cost savings to hospitals. Investors see this upside, but adoption will depend on strong clinical evidence and reimbursement pathways. (<a title=\"Non-drill brain monitoring startup CoMind raises over $100M\" href=\"https:\/\/tech.eu\/2025\/10\/20\/non-drill-brain-monitoring-startup-comind-raises-over-100m\/?utm_source=chatgpt.com\">Tech.eu<\/a>)<\/p>\n<hr \/>\n<h2><span class=\"ez-toc-section\" id=\"Risks_and_challenges\"><\/span>Risks and challenges<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Regulatory bar:<\/strong> FDA clearance\/approval requires robust multi-center clinical data demonstrating safety and equivalence (or sufficient clinical utility) compared with invasive standards. Timeline and trial outcomes are uncertain. (<a title=\"UK brain monitoring start-up goes from teenage idea to $100mn funding\" href=\"https:\/\/www.ft.com\/content\/1f41a613-c97a-4725-8715-5dd3090f5287?utm_source=chatgpt.com\">Financial Times<\/a>)<\/li>\n<li><strong>Clinical acceptance:<\/strong> Critical-care clinicians are appropriately cautious; widespread adoption requires guideline endorsements and demonstrated improvements in outcomes or workflow. (<a title=\"Non-drill brain monitoring startup CoMind raises over $100M\" href=\"https:\/\/tech.eu\/2025\/10\/20\/non-drill-brain-monitoring-startup-comind-raises-over-100m\/?utm_source=chatgpt.com\">Tech.eu<\/a>)<\/li>\n<li><strong>Technical limits:<\/strong> Measuring physiological signals through bone is hard \u2014 signal-to-noise, patient variability (skull thickness, hair, skin) and motion artefacts are real engineering hurdles. CoMind will need convincing head-to-head data. (<a title=\"Non-drill brain monitoring startup CoMind raises over $100M\" href=\"https:\/\/tech.eu\/2025\/10\/20\/non-drill-brain-monitoring-startup-comind-raises-over-100m\/?utm_source=chatgpt.com\">Tech.eu<\/a>)<\/li>\n<li><strong>Commercial &amp; reimbursement:<\/strong> Hospitals will evaluate cost, training, integration with monitoring systems and reimbursement \u2014 all will influence uptake. (<a title=\"CoMind raises $102.5M to support brain monitoring tech\" href=\"https:\/\/www.massdevice.com\/comind-raises-102m-brain-monitoring-tech\/?utm_source=chatgpt.com\">MassDevice<\/a>)<\/li>\n<\/ul>\n<hr \/>\n<h2><span class=\"ez-toc-section\" id=\"Whats_next_timeline\"><\/span>What\u2019s next \/ timeline<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Near term:<\/strong> Complete ongoing recruitment for the U.S. clinical trial(s); scale manufacturing partnerships and expand clinical sites. (<a title=\"UK brain monitoring start-up goes from teenage idea to $100mn funding\" href=\"https:\/\/www.ft.com\/content\/1f41a613-c97a-4725-8715-5dd3090f5287?utm_source=chatgpt.com\">Financial Times<\/a>)<\/li>\n<li><strong>Mid term:<\/strong> Submit regulatory dossiers (FDA) based on trial results; pursue market access pathways and early adopter hospital programs if clearance is obtained. (<a title=\"UK brain monitoring start-up goes from teenage idea to $100mn funding\" href=\"https:\/\/www.ft.com\/content\/1f41a613-c97a-4725-8715-5dd3090f5287?utm_source=chatgpt.com\">Financial Times<\/a>)<\/li>\n<li><strong>Long term:<\/strong> Broader rollout across ICUs, operating rooms and possibly ambulatory settings depending on device claims and performance. (<a title=\"Non-drill brain monitoring startup CoMind raises over $100M\" href=\"https:\/\/tech.eu\/2025\/10\/20\/non-drill-brain-monitoring-startup-comind-raises-over-100m\/?utm_source=chatgpt.com\">Tech.eu<\/a>)<\/li>\n<\/ul>\n<hr \/>\n<h2><span class=\"ez-toc-section\" id=\"Sources_further_reading\"><\/span>Sources &amp; further reading<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>CoMind press release: <em>\u201cCoMind announces $102.5m funding to redefine clinical monitoring of the brain\u201d<\/em> (company site). (<a title=\"CoMind announces $102.5m funding to redefine clinical ...\" href=\"https:\/\/www.comind.io\/news\/comind-announces-102-5m-funding-to-redefine-clinical-monitoring-of-the-brain?utm_source=chatgpt.com\">comind.io<\/a>)<\/li>\n<li>Financial Times: <em>\u201cUK brain monitoring start-up goes from teenage idea to $100mn funding\u201d<\/em> (coverage of round, founder and regulatory plans). (<a title=\"UK brain monitoring start-up goes from teenage idea to $100mn funding\" href=\"https:\/\/www.ft.com\/content\/1f41a613-c97a-4725-8715-5dd3090f5287?utm_source=chatgpt.com\">Financial Times<\/a>)<\/li>\n<li>Sifted: <em>\u201cPlural backs brain monitoring startup CoMind in $60m round\u201d<\/em> (round details &amp; investor context). (<a title=\"Plural backs brain monitoring startup CoMind in $60m round\" href=\"https:\/\/sifted.eu\/articles\/plural-brain-monitoring-comind-60m\/?utm_source=chatgpt.com\">Sifted<\/a>)<\/li>\n<li>Tech.eu: <em>\u201cNon-drill brain monitoring startup CoMind raises over $100M\u201d<\/em> (background &amp; funding). (<a title=\"Non-drill brain monitoring startup CoMind raises over $100M\" href=\"https:\/\/tech.eu\/2025\/10\/20\/non-drill-brain-monitoring-startup-comind-raises-over-100m\/?utm_source=chatgpt.com\">Tech.eu<\/a>)<\/li>\n<li>MassDevice \/ industry reporting: <em>\u201cCoMind raises $102.5M to support brain monitoring tech\u201d<\/em> (device\/clinical\/regulatory notes). (<a title=\"CoMind raises $102.5M to support brain monitoring tech\" href=\"https:\/\/www.massdevice.com\/comind-raises-102m-brain-monitoring-tech\/?utm_source=chatgpt.com\">MassDevice<\/a>)<\/li>\n<li>Founder announcement (X \/ Twitter): James Dacombe\u2019s post confirming the fundraising. (<a title=\"James Dacombe\" href=\"https:\/\/x.com\/jamesdacombe\/status\/1980145299160248535?utm_source=chatgpt.com\">X (formerly Twitter)<\/a>)<\/li>\n<\/ul>\n<hr \/>\n<p>Nice \u2014 below are <strong>3 concise case studies<\/strong> (realistic clinical vignettes based on CoMind\u2019s stated use-cases and published trial activity) plus <strong>targeted commentary<\/strong> (investor, regulatory, clinical, technical, and commercial angles). I\u2019ve cited the most important public sources at the end of each load-bearing section.<\/p>\n<hr \/>\n<h1><span class=\"ez-toc-section\" id=\"Case_studies\"><\/span>Case studies<span class=\"ez-toc-section-end\"><\/span><\/h1>\n<h3><span class=\"ez-toc-section\" id=\"Case_study_A_%E2%80%94_Neuro-critical_care_traumatic_brain_injury_TBI_%E2%80%94_earlier_intervention\"><\/span>Case study A \u2014 Neuro-critical care: traumatic brain injury (TBI) \u2014 earlier intervention<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>A 42-year-old male presents to a tertiary hospital after a road-traffic collision with moderate TBI. He\u2019s intubated and admitted to the neuro-ICU. Standard care includes neurological exam and intermittent CT, but continuous intracranial pressure (ICP) is not immediately available without an invasive bolt.<br \/>\nWith a CoMind One placed at the bedside, the ICU team receives continuous estimates of ICP, cerebral blood flow and autoregulation trends. The monitor shows a progressive rise in ICP and deteriorating autoregulation before the patient\u2019s neurological exam changes. The team escalates medical therapy (head elevation, osmotherapy) and arranges expedited CT and neurosurgical review. Early detection prevents secondary brain injury and shortens time to intervention.<br \/>\n(Background: CoMind has completed feasibility trials in London\/Barcelona and is recruiting U.S. studies to validate non-invasive measurements against invasive standards.) (<a title=\"UK brain monitoring start-up goes from teenage idea to $100mn funding\" href=\"https:\/\/www.ft.com\/content\/1f41a613-c97a-4725-8715-5dd3090f5287?utm_source=chatgpt.com\">Financial Times<\/a>)<\/p>\n<hr \/>\n<h3><span class=\"ez-toc-section\" id=\"Case_study_B_%E2%80%94_Perioperative_monitoring_in_high-risk_cardiac_surgery\"><\/span>Case study B \u2014 Perioperative monitoring in high-risk cardiac surgery<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>A 67-year-old undergoing coronary artery bypass grafting experiences intraoperative hypotension during cardiopulmonary bypass. Traditional monitoring shows systemic blood pressure changes, but brain perfusion status is uncertain. Using CoMind One in the operating theatre, the perfusionist and anaesthetist get near-real-time cerebral blood flow and autoregulation indices. Loss of autoregulation prompts adjustments in pump flows and paCO\u2082 management, preventing cerebral hypoperfusion. Post-op cognitive dysfunction risk is reduced through tailored management.<br \/>\n(Use case commonly cited by the company and reporters as a major commercial opportunity.) (<a title=\"Non-drill brain monitoring startup CoMind raises over $100M\" href=\"https:\/\/tech.eu\/2025\/10\/20\/non-drill-brain-monitoring-startup-comind-raises-over-100m\/?utm_source=chatgpt.com\">Tech.eu<\/a>)<\/p>\n<hr \/>\n<h3><span class=\"ez-toc-section\" id=\"Case_study_C_%E2%80%94_Stroke_subarachnoid_hemorrhage_monitoring_recovery_secondary_deterioration\"><\/span>Case study C \u2014 Stroke \/ subarachnoid hemorrhage (monitoring recovery &amp; secondary deterioration)<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>A patient with aneurysmal subarachnoid hemorrhage (SAH) is at risk of delayed cerebral ischemia (vasospasm). Continuous bedside cerebral blood flow trend data from a non-invasive monitor helps detect early reductions in perfusion that precede clinical decline. This triggers earlier angiographic assessment and intervention, potentially improving neurologic outcome and reducing ICU length of stay.<br \/>\n(Clinical trials and multi-center data will be required to prove outcome benefit; CoMind\u2019s published materials and trials emphasize feasibility and regulatory study plans.) (<a title=\"UK brain monitoring start-up goes from teenage idea to $100mn funding\" href=\"https:\/\/www.ft.com\/content\/1f41a613-c97a-4725-8715-5dd3090f5287?utm_source=chatgpt.com\">Financial Times<\/a>)<\/p>\n<hr \/>\n<h1><span class=\"ez-toc-section\" id=\"Comments_%E2%80%94_what_this_round_means_quick_bullets\"><\/span>Comments \u2014 what this round means (quick bullets)<span class=\"ez-toc-section-end\"><\/span><\/h1>\n<p><strong>1) Validation is the next gating item (regulatory &amp; clinical).<\/strong><br \/>\nInvestors bought into the technology and team \u2014 CoMind announced $60M in the round led by Plural, taking total to $102.5M \u2014 but FDA clearance will hinge on robust, multi-center data showing the device either matches invasive measures or provides actionable clinical value. Expect pivotal U.S. studies and tightly designed head-to-head comparisons. (<a title=\"Plural backs brain monitoring startup CoMind in $60m round\" href=\"https:\/\/sifted.eu\/articles\/plural-brain-monitoring-comind-60m?utm_source=chatgpt.com\">Sifted<\/a>)<\/p>\n<p><strong>2) Manufacturing &amp; scale: credible partners matter.<\/strong><br \/>\nPublic reporting links CoMind\u2019s scale plans to production partners (reports mention Benchmark as a manufacturing ally), which matters for regulated device quality and EU\/US supply chain readiness. Contract manufacturing capability shortens time to market once regulatory green lights arrive. (<a title=\"UK brain monitoring start-up goes from teenage idea to $100mn funding\" href=\"https:\/\/www.ft.com\/content\/1f41a613-c97a-4725-8715-5dd3090f5287?utm_source=chatgpt.com\">Financial Times<\/a>)<\/p>\n<p><strong>3) Commercial pathway: ICU + OR first, then step-down markets.<\/strong><br \/>\nHigh-value hospital settings (neuro-ICU, cardiac theatres) are the logical early adopters because they already value continuous physiologic monitoring. Wider adoption (stroke wards, general ICUs) will need evidence of cost-effectiveness and reimbursement codes. (<a title=\"Non-drill brain monitoring startup CoMind raises over $100M\" href=\"https:\/\/tech.eu\/2025\/10\/20\/non-drill-brain-monitoring-startup-comind-raises-over-100m\/?utm_source=chatgpt.com\">Tech.eu<\/a>)<\/p>\n<p><strong>4) Technical caveats \u2014 measurement variability &amp; confounders.<\/strong><br \/>\nMeasuring signals through skull\/soft tissue (hair, scalp thickness, bone heterogeneity, motion) is inherently noisy. The product\u2019s value depends on signal processing, calibration against standards, and clear failure modes. Peer-reviewed validation vs invasive ICP\/CBF remains the hard science test. (<a title=\"UK brain monitoring start-up goes from teenage idea to $100mn funding\" href=\"https:\/\/www.ft.com\/content\/1f41a613-c97a-4725-8715-5dd3090f5287?utm_source=chatgpt.com\">Financial Times<\/a>)<\/p>\n<p><strong>5) Investor signal: conviction in founder + category.<\/strong><br \/>\nA large, founder-friendly round led by Plural signals confidence in both the team (James Dacombe) and the idea that non-invasive neuromonitoring is a large, under-served market. But later rounds will price in trial results and early commercial traction. (<a title=\"Plural backs brain monitoring startup CoMind in $60m round\" href=\"https:\/\/sifted.eu\/articles\/plural-brain-monitoring-comind-60m?utm_source=chatgpt.com\">Sifted<\/a>)<\/p>\n<p><strong>6) Ethical &amp; clinical governance points.<\/strong><br \/>\nContinuous brain monitoring raises questions about alarm fatigue, interpretation responsibility (who acts on trends), data ownership and integration with electronic health records. Hospitals will demand clear clinical protocols and training. (These issues are predictable adoption friction, not unique to CoMind.) (<a title=\"CoMind \u2013 The Future of Neurotechnology is Non-Invasive\" href=\"https:\/\/www.comind.io\/?utm_source=chatgpt.com\">CoMind<\/a>)<\/p>\n<hr \/>\n<h1><span class=\"ez-toc-section\" id=\"Suggested_follow-ups_I_can_do_these_next\"><\/span>Suggested follow-ups (I can do these next)<span class=\"ez-toc-section-end\"><\/span><\/h1>\n<ul>\n<li>Convert the case studies into <strong>two slide deck slides<\/strong> (one clinical vignette + one probability\/impact slide) for investor or clinical audiences.<\/li>\n<li>Draft a <strong>short press Q&amp;A (3\u20135 FAQs)<\/strong> CoMind might publish to address clinician\/regulatory\/manufacturing questions.<\/li>\n<li>Produce a <strong>comparative table<\/strong> that maps CoMind One vs invasive ICP bolts and vs existing non-invasive modalities (TCD, NIRS) \u2014 lists metrics, strengths, evidence status.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Major funding round for brain-scan startup CoMind \u2014 full detailed report Headline: CoMind pulls in $60M Series A (part of $102.5M total) to commercialize a&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10,6],"tags":[],"class_list":["post-933896","post","type-post","status-publish","format-standard","hentry","category-gb-news","category-uk-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Major Funding Round for Brain Scan Startup CoMind - UK News &amp; Updates<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ukpostcode.org\/content\/major-funding-round-for-brain-scan-startup-comind\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Major Funding Round for Brain Scan Startup CoMind - UK News &amp; Updates\" \/>\n<meta property=\"og:description\" content=\"Major funding round for brain-scan startup CoMind \u2014 full detailed report Headline: CoMind pulls in $60M Series A (part of $102.5M total) to commercialize a...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ukpostcode.org\/content\/major-funding-round-for-brain-scan-startup-comind\/\" \/>\n<meta property=\"og:site_name\" content=\"UK News &amp; Updates\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-22T14:13:13+00:00\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ukpostcode.org\/content\/major-funding-round-for-brain-scan-startup-comind\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ukpostcode.org\/content\/major-funding-round-for-brain-scan-startup-comind\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/ukpostcode.org\/content\/#\/schema\/person\/5529805dee92503827c0c27ed13d55a3\"},\"headline\":\"Major Funding Round for Brain Scan Startup CoMind\",\"datePublished\":\"2025-10-22T14:13:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ukpostcode.org\/content\/major-funding-round-for-brain-scan-startup-comind\/\"},\"wordCount\":1820,\"publisher\":{\"@id\":\"https:\/\/ukpostcode.org\/content\/#organization\"},\"articleSection\":[\"GB News\",\"UK News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ukpostcode.org\/content\/major-funding-round-for-brain-scan-startup-comind\/\",\"url\":\"https:\/\/ukpostcode.org\/content\/major-funding-round-for-brain-scan-startup-comind\/\",\"name\":\"Major Funding Round for Brain Scan Startup CoMind - UK News &amp; Updates\",\"isPartOf\":{\"@id\":\"https:\/\/ukpostcode.org\/content\/#website\"},\"datePublished\":\"2025-10-22T14:13:13+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/ukpostcode.org\/content\/major-funding-round-for-brain-scan-startup-comind\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ukpostcode.org\/content\/major-funding-round-for-brain-scan-startup-comind\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ukpostcode.org\/content\/major-funding-round-for-brain-scan-startup-comind\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ukpostcode.org\/content\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Major Funding Round for Brain Scan Startup CoMind\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ukpostcode.org\/content\/#website\",\"url\":\"https:\/\/ukpostcode.org\/content\/\",\"name\":\"UK News &amp; Updates\",\"description\":\"UK Post Code\",\"publisher\":{\"@id\":\"https:\/\/ukpostcode.org\/content\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ukpostcode.org\/content\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ukpostcode.org\/content\/#organization\",\"name\":\"UK News &amp; Updates\",\"url\":\"https:\/\/ukpostcode.org\/content\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ukpostcode.org\/content\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ukpostcode.org\/content\/wp-content\/uploads\/2023\/09\/cropped-uk-logo-1.png\",\"contentUrl\":\"https:\/\/ukpostcode.org\/content\/wp-content\/uploads\/2023\/09\/cropped-uk-logo-1.png\",\"width\":307,\"height\":85,\"caption\":\"UK News &amp; Updates\"},\"image\":{\"@id\":\"https:\/\/ukpostcode.org\/content\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ukpostcode.org\/content\/#\/schema\/person\/5529805dee92503827c0c27ed13d55a3\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ukpostcode.org\/content\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/6aac6e3af4be1d6689e924bbaccd84fc0cc6c5f6680490dc6f0a1f09b87d57f1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/6aac6e3af4be1d6689e924bbaccd84fc0cc6c5f6680490dc6f0a1f09b87d57f1?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/ukpostcode.org\/content\"],\"url\":\"https:\/\/ukpostcode.org\/content\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Major Funding Round for Brain Scan Startup CoMind - UK News &amp; Updates","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ukpostcode.org\/content\/major-funding-round-for-brain-scan-startup-comind\/","og_locale":"en_US","og_type":"article","og_title":"Major Funding Round for Brain Scan Startup CoMind - UK News &amp; Updates","og_description":"Major funding round for brain-scan startup CoMind \u2014 full detailed report Headline: CoMind pulls in $60M Series A (part of $102.5M total) to commercialize a...","og_url":"https:\/\/ukpostcode.org\/content\/major-funding-round-for-brain-scan-startup-comind\/","og_site_name":"UK News &amp; Updates","article_published_time":"2025-10-22T14:13:13+00:00","author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ukpostcode.org\/content\/major-funding-round-for-brain-scan-startup-comind\/#article","isPartOf":{"@id":"https:\/\/ukpostcode.org\/content\/major-funding-round-for-brain-scan-startup-comind\/"},"author":{"name":"admin","@id":"https:\/\/ukpostcode.org\/content\/#\/schema\/person\/5529805dee92503827c0c27ed13d55a3"},"headline":"Major Funding Round for Brain Scan Startup CoMind","datePublished":"2025-10-22T14:13:13+00:00","mainEntityOfPage":{"@id":"https:\/\/ukpostcode.org\/content\/major-funding-round-for-brain-scan-startup-comind\/"},"wordCount":1820,"publisher":{"@id":"https:\/\/ukpostcode.org\/content\/#organization"},"articleSection":["GB News","UK News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/ukpostcode.org\/content\/major-funding-round-for-brain-scan-startup-comind\/","url":"https:\/\/ukpostcode.org\/content\/major-funding-round-for-brain-scan-startup-comind\/","name":"Major Funding Round for Brain Scan Startup CoMind - UK News &amp; Updates","isPartOf":{"@id":"https:\/\/ukpostcode.org\/content\/#website"},"datePublished":"2025-10-22T14:13:13+00:00","breadcrumb":{"@id":"https:\/\/ukpostcode.org\/content\/major-funding-round-for-brain-scan-startup-comind\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ukpostcode.org\/content\/major-funding-round-for-brain-scan-startup-comind\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ukpostcode.org\/content\/major-funding-round-for-brain-scan-startup-comind\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ukpostcode.org\/content\/"},{"@type":"ListItem","position":2,"name":"Major Funding Round for Brain Scan Startup CoMind"}]},{"@type":"WebSite","@id":"https:\/\/ukpostcode.org\/content\/#website","url":"https:\/\/ukpostcode.org\/content\/","name":"UK News &amp; Updates","description":"UK Post Code","publisher":{"@id":"https:\/\/ukpostcode.org\/content\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ukpostcode.org\/content\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ukpostcode.org\/content\/#organization","name":"UK News &amp; Updates","url":"https:\/\/ukpostcode.org\/content\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ukpostcode.org\/content\/#\/schema\/logo\/image\/","url":"https:\/\/ukpostcode.org\/content\/wp-content\/uploads\/2023\/09\/cropped-uk-logo-1.png","contentUrl":"https:\/\/ukpostcode.org\/content\/wp-content\/uploads\/2023\/09\/cropped-uk-logo-1.png","width":307,"height":85,"caption":"UK News &amp; Updates"},"image":{"@id":"https:\/\/ukpostcode.org\/content\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ukpostcode.org\/content\/#\/schema\/person\/5529805dee92503827c0c27ed13d55a3","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ukpostcode.org\/content\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/6aac6e3af4be1d6689e924bbaccd84fc0cc6c5f6680490dc6f0a1f09b87d57f1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/6aac6e3af4be1d6689e924bbaccd84fc0cc6c5f6680490dc6f0a1f09b87d57f1?s=96&d=mm&r=g","caption":"admin"},"sameAs":["https:\/\/ukpostcode.org\/content"],"url":"https:\/\/ukpostcode.org\/content\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/ukpostcode.org\/content\/wp-json\/wp\/v2\/posts\/933896","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ukpostcode.org\/content\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ukpostcode.org\/content\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ukpostcode.org\/content\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ukpostcode.org\/content\/wp-json\/wp\/v2\/comments?post=933896"}],"version-history":[{"count":1,"href":"https:\/\/ukpostcode.org\/content\/wp-json\/wp\/v2\/posts\/933896\/revisions"}],"predecessor-version":[{"id":933897,"href":"https:\/\/ukpostcode.org\/content\/wp-json\/wp\/v2\/posts\/933896\/revisions\/933897"}],"wp:attachment":[{"href":"https:\/\/ukpostcode.org\/content\/wp-json\/wp\/v2\/media?parent=933896"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ukpostcode.org\/content\/wp-json\/wp\/v2\/categories?post=933896"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ukpostcode.org\/content\/wp-json\/wp\/v2\/tags?post=933896"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}